Citeline Podcasts

John Tushar, Teleflex Medical's president and general manager, surgery spoke to Medtech Insight at the SAGES annual meeting in March about the company’s novel portfolio of miniaturized percutaneous surgical instruments, the market opportunity for this technology, and how percutaneous laparoscopy could be an MIS game-changer.

John Tushar, Teleflex Medical's president and general manager, surgery spoke to Medtech Insight at the SAGES annual meeting in March about the company’s novel portfolio of miniaturized percutaneous surgical instruments, the market opportunity for this technology, and how percutaneous laparoscopy could be an MIS game-changer.

On this week's podcast, Gray Sheet journalists talked about the latest developments in the Senate toward a "medical innovation" legislative package, the continuing lab-developed test debate, ideas for device interoperability, off-label legal considerations and some business and R&D news.

On this week's podcast, Gray Sheet journalists talked about the latest developments in the Senate toward a "medical innovation" legislative package, the continuing lab-developed test debate, ideas for device interoperability, off-label legal considerations and some business and R&D news.

On this week's podcast, Gray Sheet journalists talked about the latest developments in the Senate toward a "medical innovation" legislative package, the continuing lab-developed test debate, ideas for device interoperability, off-label legal considerations and some business and R&D news.

In our latest European edition of the podcast, Clinica's Amanda Maxwell discusses where things stand with the move toward "scrutiny" mechanisms for high-risk devices; what the revised international ISO 13485 quality systems standard means for the EU; and regulatory questions around cranial stimulation devices with nonmedical claims.

In our latest European edition of the podcast, Clinica's Amanda Maxwell discusses where things stand with the move toward "scrutiny" mechanisms for high-risk devices; what the revised international ISO 13485 quality systems standard means for the EU; and regulatory questions around cranial stimulation devices with nonmedical claims.

In our latest European edition of the podcast, Clinica's Amanda Maxwell discusses where things stand with the move toward "scrutiny" mechanisms for high-risk devices; what the revised international ISO 13485 quality systems standard means for the EU; and regulatory questions around cranial stimulation devices with nonmedical claims.

Todd Usen, President, Medical Systems Group at Olympus spoke to Medtech Insight at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) annual meeting in Boston in March regarding the company's new VISERA 4K ultra-high definition (UHD) imaging system, the strategy behind the Sony Olympus Medical Solutions joint-venture, the market potential for this technology, and how Olympus plans to position 4K UHD imaging in the market for minimally-invasive surgery products.

ISO 13485 Redo Takes Front Seat In Exclusive Podcast With Ex-FDA International Quality Systems Expert Kim Trautman.